Getting the Most from Medical-Use Claims in Australia
Australia stands apart from many other key jurisdictions in allowing first and second medical use claims drafted as “method of medical treatment” or “Swiss-form” claims.
Australia stands apart from many other key jurisdictions in allowing first and second medical use claims drafted as “method of medical treatment” or “Swiss-form” claims.
FibroGen Inc. v Akebia Therapeutics Inc. and another company; Astellas Pharma Inc. v Akebia Therapeutics Inc. and other companies [2021] EWCA Civ 1279 What are the
When evaluating the novelty of claims in life sciences and pharmaceutical, compared with EPO, the examination practice in China is more stringent when determining whether
The Canadian Patent Act imposes an unyielding relationship between the requirement for a written description of the invention and claims for which patent protection is sought. A
Prosecution pathway for pharma & bio patents in india – part 1 The Indian pharmaceutical industry, often referred to as “the pharmacy of the world”
Considering the IP and Legal Implications of Gene Editing Global food security is increasingly challenging in light of population growth, the impact of climate change
United States
1 North State Street,
15th floor
Chicago, IL 60602
__
82 Nassau St #60492
New York, NY 10038
Singapore
7 Temasek Boulevard, #12-07
Suntec Tower One
Hong Kong
Tung Wai Commercial Building,
Suite 1404
109-111 Gloucester Road, Wan Chai
Israel
Naimi Center,
2nd Floor
Yitzhak Rabin 2
Copyright © 2022. All Rights Reserved.